AlexeyAleshinMD

PubMed

• Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.
  Jacqueline A Shaw, Karen Page, Evie Wren, Elza C de Bruin, Ekaterina Kalashnikova, Robert Hastings, Rob McEwen, Eddie Zhang, Marc Wadsley, Emmanuel Acheampong, Derek R...> ;JCO Precision Oncology. 2024 Apr 1
• 1 citations
  Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early...
  Aaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, Kevin L M Chua, Angela Takano, Boon-Hean Ong, Tina P T Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesva...> ;Cancer. 2024 May 15
• Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.
  Ekaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, Antony Tin, Shifra Krinshpun, Raheleh Salari, Carly Bess Scalise, Rosalyn Ram, Meenakshi Malhotra, ...> ;Molecular Oncology. 2023 Dec 1
• 3 citations
  Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.
  Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, George Laliotis, Philippe Lamy, Emil Christensen, Derrick Renner, Tine G Andreasen, Naja Lange, Shruti Sh...> ;Clinical Cancer Research. 2023 Dec 1
• 1 citations
  Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carc...
  Thomas Powles, Zoe June Assaf, Viraj Degaonkar, Petros Grivas, Maha Hussain, Stephane Oudard, Jürgen E Gschwend, Peter Albers, Daniel Castellano, Hiroyuki Nishiyama, S...> ;European Urology. 2024 Feb 1
• 15 citations
  Practical recommendations for using ctDNA in clinical decision making.
  Stacey A Cohen, Minetta C Liu, Alexey Aleshin> ;Nature. 2023 Jul 1
• 10 citations
  Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
  Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen...> ;Cancer Cell. 2023 Jun 12
• 4 citations
  Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
  Georges Azzi, Mehrad Tavallai, Vasily N Aushev, Allyson Koyen Malashevich, Gregory P Botta, Mohamedtaki A Tejani, Diana Hanna, Shifra Krinshpun, Meenakshi Malhotra, Ad...> ;The Oncologist. 2023 Mar 17
• 12 citations
  Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
  Zeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, Sumedha Sudhaman, Turkan Ozturk Topcu, Matt Nichols, Justin Martin, Katherine M Bui, Charuta C Palsuledesai, M...> ;Cancer. 2023 Jun 1
• Reply to S. Chakrabarti and A. Mahipal.
  Brandon M Huffman, Adham Jurdi, Alexey Aleshin, Minetta C Liu, Samuel J Klempner> ;JCO Precision Oncology. 2023 Mar 1
• 5 citations
  Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab.
  Maya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, Chang Xu, Jessica K Lee, Lo-Bin Chang, Russell W Madison, Frank Lin, Eugene Hsu, Vipul Kumar Patel, Alexey Alesh...> ;Molecular Oncology. 2023 Feb 1
• Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitorin...
  Thomas Powles, Amanda Young, Halla Nimeiri, Russell W Madison, Alexander Fine, Daniel R Zollinger, Yanmei Huang, Chang Xu, Ole V Gjoerup, Vasily N Aushev, Hsin-Ta Wu, ...> ;Frontiers in Oncology. 2023 Jan 1
• 90 citations
  Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.
  Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura, Hiroki Yukami, Saori Mishima, Hideaki Bando, Hiromichi Shirasu, Kentaro Yamazaki, Jun Watanabe, Masahito Kotaka, Keiji Hir...> ;Nature Medicine. 2023 Jan 1
• 2 citations
  Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
  Maggie Zhou, Nam Bui, Richa Rathore, Sumedha Sudhaman, Giby V George, Allyson K Malashevich, Meenakshi Malhotra, Minetta C Liu, Alexey Aleshin, Kristen N Ganjoo> ;Cancers. 2022 Dec 27
• 16 citations
  Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.
  Brandon M Huffman, Vasily N Aushev, Griffin L Budde, Joseph Chao, Farshid Dayyani, Diana Hanna, Gregory P Botta, Daniel V T Catenacci, Steven B Maron, Shifra Krinshpun...> ;JCO Precision Oncology. 2022 Dec 1
• 12 citations
  Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic C...
  Sara Lonardi, Halla Nimeiri, Chang Xu, Daniel R Zollinger, Russell W Madison, Alexander D Fine, Ole Gjoerup, Cosimo Rasola, Valentina Angerilli, Shruti Sharma, Hsin-Ta...> ;International Journal of Molecular Sciences. 2022 Sep 29
• 14 citations
  Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer.
  June Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, William Pierson, Karen Smith-McCune, Geovanni Pineda, Reena Marie Vattakalam, Alexandra Ross, Meredith Mills, Ca...> ;Gynecologic Oncology. 2022 Nov 1
• 16 citations
  Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.
  Frédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, Françoise Rothé, Hsin-Ta Wu, Mustafa Balcioglu, Ekaterina Kalashnikova, Delphine Vincent, Giulia Viglietti, An...> ;JCO Precision Oncology. 2022 Sep 1
• 50 citations
  Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
  Bernadett Szabados, Mark Kockx, Zoe June Assaf, Pieter-Jan van Dam, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb, Michiel S Van Der Heijden, Albert Font Pous, Gw...> ;European Urology. 2022 Aug 1
• Reply to F. Dayyani et al.
  Pashtoon M Kasi, Gordon Fehringer, Alexey Aleshin, Scott Kopetz> ;JCO Precision Oncology. 2022 Jul 1
• 4 citations
  BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.
  Pashtoon Murtaza Kasi, Sakti Chakrabarti, Sarah Sawyer, Michael Krainock, Andrew Poklepovic, George Ansstas, Minu Maninder, Meenakshi Malhotra, Joe Ensor, Ling Gao, Ze...> ;BMJ Open. 2022 May 30
• 5 citations
  Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.
  Georges Azzi, Shifra Krinshpun, Antony Tin, Minu Maninder, Allyson Koyen Malashevich, Meenakshi Malhotra, Ruben Ruiz Vega, Paul R Billings, Angel Rodriguez, Alexey Ale...> ;Case Reports in Oncology. 2022 May 2
• 30 citations
  Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.
  Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T Li, Lajos Pusztai, Vasily N Aushev, Ekat...> ;JCO Precision Oncology. 2022 Mar 1
• 15 citations
  Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorec...
  Pashtoon Murtaza Kasi, Griffin Budde, Michael Krainock, Vasily N Aushev, Allyson Koyen Malashevich, Meenakshi Malhotra, Perry Olshan, Paul R Billings, Alexey Aleshin> ;Journal for Immunotherapy of Cancer. 2022 Jan 1
• 8 citations
  Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.
  Binod Dhakal, Shruti Sharma, Mustafa Balcioglu, Svetlana Shchegrova, Meenakshi Malhotra, Bernhard Zimmermann, Paul R Billings, Alexandra Harrington, Himanshu Sethi, Al...> ;Frontiers in Oncology. 2022 Jan 1
• Join now to see all

Abstracts/Posters

• A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents
  Alexey Aleshin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Single-Cell Mutational Profiling of Clonal Evolution in De Novo AML during Therapy and Relapse 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018